These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 32596297)
1. Different Development Forms of Local Allergic Rhinitis towards Birch. Bozek A; Winterstein J; Galuszka B; Jarzab J Biomed Res Int; 2020; 2020():3408561. PubMed ID: 32596297 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis. Bożek A; Kołodziejczyk K; Jarząb J Ann Allergy Asthma Immunol; 2018 Jan; 120(1):53-58. PubMed ID: 29273130 [TBL] [Abstract][Full Text] [Related]
3. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma. Wahn U; Bachert C; Heinrich J; Richter H; Zielen S Allergy; 2019 Mar; 74(3):594-604. PubMed ID: 30183091 [TBL] [Abstract][Full Text] [Related]
4. Potential Differences between Local and Systemic Allergic Rhinitis Induced by Birch Pollen. Bozek A; Zalejska Fiolka J; Krajewska Wojtys A; Galuszka B; Cudak A Int Arch Allergy Immunol; 2020; 181(11):831-838. PubMed ID: 32772017 [TBL] [Abstract][Full Text] [Related]
5. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma. Pfaar O; Bachert C; Kuna P; Panzner P; Džupinová M; Klimek L; van Nimwegen MJ; Boot JD; Yu D; Opstelten DJE; de Kam PJ J Allergy Clin Immunol; 2019 Mar; 143(3):970-977. PubMed ID: 30508538 [TBL] [Abstract][Full Text] [Related]
6. Allergen specific immunotherapy attenuates early and late phase reactions in lower airways of birch pollen asthmatic patients: a double blind placebo-controlled study. Arvidsson MB; Löwhagen O; Rak S Allergy; 2004 Jan; 59(1):74-80. PubMed ID: 14674937 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of D. pteronyssinus immunotherapy in local allergic rhinitis: a double-blind placebo-controlled clinical trial. Rondón C; Campo P; Salas M; Aranda A; Molina A; González M; Galindo L; Mayorga C; Torres MJ; Blanca M Allergy; 2016 Jul; 71(7):1057-61. PubMed ID: 27008542 [TBL] [Abstract][Full Text] [Related]
8. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects. Winther L; Malling HJ; Mosbech H Allergy; 2000 Sep; 55(9):827-35. PubMed ID: 11003446 [TBL] [Abstract][Full Text] [Related]
9. Responders and nonresponders to pharmacotherapy and allergen immunotherapy. Jakalski M; Bozek A; Canonica GW Hum Vaccin Immunother; 2019; 15(12):2896-2902. PubMed ID: 31070995 [TBL] [Abstract][Full Text] [Related]
10. Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen. Ahlbeck L; Ahlberg E; Björkander J; Aldén C; Papapavlou G; Palmberg L; Nyström U; Retsas P; Nordenfelt P; Togö T; Johansen P; Rolander B; Duchén K; Jenmalm MC Clin Exp Allergy; 2022 Jun; 52(6):747-759. PubMed ID: 35332591 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C J Allergy Clin Immunol; 2016 Jul; 138(1):162-8. PubMed ID: 27373329 [TBL] [Abstract][Full Text] [Related]
12. Preventive Effect of Allergen Immunotherapy on Asthma and New Sensitizations. Gradman J; Halken S J Allergy Clin Immunol Pract; 2021 May; 9(5):1813-1817. PubMed ID: 33746088 [TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study. Bødtger U; Poulsen LK; Jacobi HH; Malling HJ Allergy; 2002 Apr; 57(4):297-305. PubMed ID: 11906359 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis. Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533 [TBL] [Abstract][Full Text] [Related]
15. Case Report: Safe and Effective Sublingual Birch Allergen Immunotherapy in Two HIV-Positive Patients. Latysheva E; Nazarova E; Latysheva T; Ilina N Front Immunol; 2021; 12():599955. PubMed ID: 34385997 [TBL] [Abstract][Full Text] [Related]
16. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. Hylander T; Latif L; Petersson-Westin U; Cardell LO J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268 [TBL] [Abstract][Full Text] [Related]
17. A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects. Hjalmarsson E; Hellkvist L; Karlsson A; Winquist O; Kumlien Georén S; Westin U; Cardell LO J Investig Allergol Clin Immunol; 2023 Oct; 33(5):362-372. PubMed ID: 37843385 [TBL] [Abstract][Full Text] [Related]
18. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy. Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570 [TBL] [Abstract][Full Text] [Related]
19. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study. Cirla AM; Cirla PE; Parmiani S; Pecora S Allergol Immunopathol (Madr); 2003; 31(1):31-43. PubMed ID: 12573207 [TBL] [Abstract][Full Text] [Related]
20. New European Academy of Allergy and Clinical Immunology definition on pollen season mirrors symptom load for grass and birch pollen-induced allergic rhinitis. Karatzas K; Katsifarakis N; Riga M; Werchan B; Werchan M; Berger U; Pfaar O; Bergmann KC Allergy; 2018 Sep; 73(9):1851-1859. PubMed ID: 29791010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]